CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cliniphar Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cliniphar Ltd
5F, OMM Bldg., 1-7-31, Otemae, Chuo-ku
Phone: +81 669419288p:+81 669419288 OSAKA-SHI, OSK  540-0008  Japan Ticker: 432A432A

Business Summary
Cliniphar Ltd is a Japan-based company primarily engaged in the pharmaceutical wholesale business. The Company operates its businesses through the pharmaceutical wholesale segment. The Segment supplies prescription and over-the-counter drugs in Japan to domestic and international customers who possess the appropriate licenses, including medical institutions, pharmacies and peer wholesalers. The Company also manages group operations, including the operation, system development and maintenance of its pharmaceutical e-commerce (EC) platform. The Company is also engaged in sales operations, procurement and product management. The Company also accepts traditional order methods including telephone, email and fax, maintaining a stable and flexible supply system alongside online orders. The Company is focusing on its domestic and international e-commerce platforms named Kosei Market and synapse, which embody the digital transformation (DX) of pharmaceutical distribution.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20253/31/2025-----

General Information
Number of Employees: 15 (As of 3/31/2025)
Outstanding Shares: 1,000,000 (As of 10/7/2025)
Stock Exchange: TYO


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, October 13, 2025